BIOMAT Database Logo BIOMAT Database Logo

Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII. 2017

Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.

Missense mutation is the most common mutation type in hemophilia. However, the majority of missense mutations remain uncharacterized. Here we characterize how hemophilia mutations near the unused N-glycosylation site of the A2 domain (N582) of FVIII affect protein conformation and intracellular trafficking. N582 is located in the middle of a short 310-helical turn (D580-S584), in which most amino acids have multiple hemophilia mutations. All 14 missense mutations found in this 310-helix reduced secretion levels of the A2 domain and full-length FVIII. Secreted mutants have decreased activities relative to WT FVIII. Selected mutations also lead to partial glycosylation of N582, suggesting that rapid folding of local conformation prevents glycosylation of this site in wild-type FVIII. Protease sensitivity, stability and degradation of the A2 domain vary among mutants, and between non-glycosylated and glycosylated species of the same mutant. Most of the mutants interact with the ER chaperone BiP, while only mutants with aberrant glycosylation interact with calreticulin. Our results show that the short 310-helix from D580 to S584 is critical for proper biogenesis of the A2 domain and FVIII, and reveal a range of molecular mechanisms by which FVIII missense mutations lead to moderate to severe hemophilia A.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004721 Endoplasmic Reticulum A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed) Ergastoplasm,Reticulum, Endoplasmic
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII.
March 2018, The Biochemical journal,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
Factor VIII C2 domain missense mutations exhibit defective trafficking of biologically functional proteins.
October 1996, The Journal of biological chemistry,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.
April 2017, Haematologica,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.
January 1998, Blood,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
Modified expression of coagulation factor VIII by addition of a glycosylation site at the N terminus of the protein.
February 2008, Annals of hematology,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
Intracellular trafficking of factor VIII to von Willebrand factor storage granules.
February 1998, The Journal of clinical investigation,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
[Glycosylation and L303e/F309S mutations improve intein-mediated splicing of the split coagulation factor VIII].
November 2010, Yao xue xue bao = Acta pharmaceutica Sinica,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
Contribution of Factor VIII A2 Domain Residues 400-409 to a Factor X-Interactive Site in the Factor Xase Complex.
May 2018, Thrombosis and haemostasis,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
In silico analyses of missense mutations in coagulation factor VIII: identification of severity determinants of haemophilia A.
September 2015, Haemophilia : the official journal of the World Federation of Hemophilia,
Wei Wei, and Chunlei Zheng, and Min Zhu, and Xiaofan Zhu, and Renchi Yang, and Saurav Misra, and Bin Zhang
T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.
November 2004, Journal of thrombosis and haemostasis : JTH,
Copied contents to your clipboard!